blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2228039

EP2228039 - Injector for intraocular lens system [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.02.2017
Database last updated on 24.04.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR
published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Visiogen, Inc.
4 Jenner Street, Suite 180
Irvine, CA 92618 / US
[2010/37]
Inventor(s)01 / Tsai, George
27481 Almendra
Mission Viejo, CA 92691 / US
 [2010/37]
Representative(s)Raynor, Simon Mark, et al
Murgitroyd & Company Milton Keynes
Studio H1B
297 Upper Fourth Street
Witan Studios
Milton Keynes MK9 1EH / GB
[N/P]
Former [2016/13]Raynor, Simon Mark, et al
Urquhart-Dykes & Lord LLP
Altius House
1 North Fourth Street
Milton Keynes MK9 1NE / GB
Former [2010/37]Raynor, Simon Mark, et al
Urquhart-Dykes & Lord LLP Midsummer House 413 Midsummer Boulevard
Central Milton Keynes MK9 3BN / GB
Application number, filing date10006514.301.02.2005
[2010/37]
Priority number, dateUS20040541429P02.02.2004         Original published format: US 541429 P
US2005004615428.01.2005         Original published format: US 46154
[2010/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2228039
Date:15.09.2010
Language:EN
[2010/37]
Type: B1 Patent specification 
No.:EP2228039
Date:30.03.2016
Language:EN
[2016/13]
Search report(s)(Supplementary) European search report - dispatched on:EP13.08.2010
ClassificationIPC:A61F2/16
[2010/37]
CPC:
A61F2/1678 (EP,US); A61F2/1648 (EP,US); A61F2/1662 (US);
A61F2/167 (US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/13]
Former [2010/37]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Injektor für Intraokularlinsensystem[2010/37]
English:Injector for intraocular lens system[2010/37]
French:Injecteur pour système de lentille intraoculaire[2010/37]
Examination procedure16.12.2010Amendment by applicant (claims and/or description)
22.02.2011Examination requested  [2011/14]
23.10.2015Communication of intention to grant the patent
27.01.2016Fee for grant paid
27.01.2016Fee for publishing/printing paid
27.01.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP05722620.1  / EP1711129
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050722620) is  25.07.2008
Opposition(s)03.01.2017No opposition filed within time limit [2017/10]
Fees paidRenewal fee
23.06.2010Renewal fee patent year 03
23.06.2010Renewal fee patent year 04
23.06.2010Renewal fee patent year 05
23.06.2010Renewal fee patent year 06
23.02.2011Renewal fee patent year 07
07.02.2012Renewal fee patent year 08
07.02.2013Renewal fee patent year 09
07.02.2014Renewal fee patent year 10
13.02.2015Renewal fee patent year 11
08.02.2016Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.02.2005
AT30.03.2016
BE30.03.2016
BG30.03.2016
CY30.03.2016
CZ30.03.2016
DK30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
IT30.03.2016
LT30.03.2016
MC30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SI30.03.2016
SK30.03.2016
TR30.03.2016
GR01.07.2016
IS30.07.2016
PT01.08.2016
[2020/15]
Former [2019/46]HU01.02.2005
AT30.03.2016
BE30.03.2016
BG30.03.2016
CY30.03.2016
CZ30.03.2016
DK30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
IT30.03.2016
LT30.03.2016
MC30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SI30.03.2016
SK30.03.2016
GR01.07.2016
IS30.07.2016
PT01.08.2016
Former [2019/39]HU01.02.2005
AT30.03.2016
BE30.03.2016
BG30.03.2016
CZ30.03.2016
DK30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
IT30.03.2016
LT30.03.2016
MC30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SI30.03.2016
SK30.03.2016
GR01.07.2016
IS30.07.2016
PT01.08.2016
Former [2019/31]HU01.02.2005
AT30.03.2016
BE30.03.2016
CZ30.03.2016
DK30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
IT30.03.2016
LT30.03.2016
MC30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SI30.03.2016
SK30.03.2016
GR01.07.2016
IS30.07.2016
PT01.08.2016
Former [2017/47]AT30.03.2016
BE30.03.2016
CZ30.03.2016
DK30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
IT30.03.2016
LT30.03.2016
MC30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SI30.03.2016
SK30.03.2016
GR01.07.2016
IS30.07.2016
PT01.08.2016
Former [2017/37]AT30.03.2016
BE30.03.2016
CZ30.03.2016
DK30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
IT30.03.2016
LT30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SI30.03.2016
SK30.03.2016
GR01.07.2016
IS30.07.2016
PT01.08.2016
Former [2017/07]AT30.03.2016
BE30.03.2016
CZ30.03.2016
DK30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
IT30.03.2016
LT30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SK30.03.2016
GR01.07.2016
IS30.07.2016
PT01.08.2016
Former [2017/03]AT30.03.2016
BE30.03.2016
CZ30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
IT30.03.2016
LT30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SK30.03.2016
GR01.07.2016
IS30.07.2016
PT01.08.2016
Former [2016/51]AT30.03.2016
CZ30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
LT30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SK30.03.2016
GR01.07.2016
IS30.07.2016
PT01.08.2016
Former [2016/50]AT30.03.2016
CZ30.03.2016
EE30.03.2016
ES30.03.2016
FI30.03.2016
LT30.03.2016
PL30.03.2016
RO30.03.2016
SE30.03.2016
SK30.03.2016
GR01.07.2016
IS30.07.2016
Former [2016/49]EE30.03.2016
FI30.03.2016
LT30.03.2016
PL30.03.2016
SE30.03.2016
GR01.07.2016
IS30.07.2016
Former [2016/48]FI30.03.2016
LT30.03.2016
SE30.03.2016
GR01.07.2016
IS30.07.2016
Former [2016/39]FI30.03.2016
LT30.03.2016
SE30.03.2016
GR01.07.2016
Former [2016/36]FI30.03.2016
LT30.03.2016
GR01.07.2016
Former [2016/35]FI30.03.2016
GR01.07.2016
Documents cited:Search[A]WO9513022  (IOVISION INC [US]) [A] 1,2,7,10,12,13 * page 14, line 24 - page 15, line 2 * * page 16, line 31 - page 17, line 17; figure 13 *;
 [A]US5507806  (BLAKE LARRY W [US]) [A] 1-4,7-14 * column 4, line 58 - column 5, line 65; figures 1,2 *;
 [A]US2001020171  (HEYMAN THOMAS M [US], et al) [A] 1,7-10,12,13 * paragraphs [0038] , [0039]; figures 1,12,16; claim 1 *;
 [A]US2003158560  (PORTNEY VALDEMAR [US]) [A] 5,6* claim 1 *;
 [ADP]WO2004073560  (VISIOGEN INC [US], et al) [ADP] 1-14 * paragraphs [0067] , [0071]; figures 15,16,21; claims 3-5,8-13 *
by applicantUS2003078656
 US20030637376
 US20040958871
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.